TABLE 2.
The effect of PL-02 supplementation combined with RT on biochemical assessments of serum at the end of the experiment.
| Characteristics | SC | PL-02 | RT | PL-02 + RT | Main factor p-value |
||
| RT | PL-02 | RT + PL-02 | |||||
| AST (U/L) | 126 ± 7b | 127 ± 13b | 92 ± 6a | 92 ± 6a | < 0.0010 | 0.9835 | 0.9505 |
| ALT (U/L) | 44 ± 12b | 43 ± 8b | 38 ± 8ab | 34 ± 6a | 0.0230 | 0.4374 | 0.5662 |
| TC (mg/dL) | 135 ± 13 | 133 ± 14 | 136 ± 10 | 137 ± 8 | 0.4886 | 0.8894 | 0.7225 |
| TG (mg/dL) | 102 ± 9 | 106 ± 6 | 101 ± 7 | 106 ± 5 | 0.8440 | 0.0931 | 1.0000 |
| CK (U/L) | 390 ± 67 | 379 ± 64 | 380 ± 52 | 362 ± 43 | 0.5173 | 0.4903 | 0.8715 |
| BUN (mg/dL) | 25.3 ± 6.2 | 25.3 ± 2.0 | 23.6 ± 1.7 | 23.3 ± 2.2 | 0.1476 | 0.9443 | 0.9206 |
| CREA (mg/dL) | 0.38 ± 0.02 | 0.39 ± 0.02 | 0.39 ± 0.02 | 0.39 ± 0.01 | 0.4287 | 0.9295 | 0.9295 |
| UA (mg/dL) | 1.6 ± 0.3 | 1.6 ± 0.6 | 1.6 ± 0.4 | 1.5 ± 0.3 | 0.9670 | 0.9014 | 0.9670 |
| ALB (g/dL) | 3.0 ± 0.1 | 3.0 ± 0.1 | 3.0 ± 0.1 | 3.0 ± 0.1 | 0.7890 | 0.6993 | 0.9053 |
| TP (g/dL) | 5.7 ± 0.3 | 5.6 ± 0.3 | 5.6 ± 0.2 | 5.6 ± 0.2 | 0.7331 | 0.5403 | 0.3103 |
| Glucose (mg/dL) | 191 ± 12 | 194 ± 16 | 208 ± 18 | 205 ± 11 | 0.0145 | 0.9904 | 0.5573 |
Data are expressed as mean ± SD and the same row with different letters (a,b) differ significantly at p < 0.05 by two-way ANOVA.
AST, aspartate aminotransferase; ALT, alanine aminotransferase; TC, total cholesterol; TG, triglycerides; CK, creatine kinase; ALB, albumin; BUN, blood urea nitrogen; CREA, creatinine; UA, urea acid; TP, total protein.